What is MRSA and how does it differ from other staph infections. How can you recognize the symptoms of MRSA. What are the most effective treatments for MRSA infections. How can you prevent the spread of MRSA in your community. What steps should parents take if they suspect their child has MRSA.

Understanding MRSA: A Resistant Staph Infection

MRSA, or Methicillin-resistant Staphylococcus aureus, is a type of staph bacteria that has developed resistance to common antibiotics. This makes MRSA infections particularly challenging to treat and potentially more dangerous than typical staph infections.

Why is MRSA resistant to antibiotics? The bacteria have evolved to withstand the effects of methicillin, an antibiotic traditionally used to combat staph infections. This resistance has developed due to the overuse and misuse of antibiotics, allowing the bacteria to adapt and survive.

The Prevalence of Staph Bacteria

Many people carry staph bacteria on their skin or in their noses without experiencing any harmful effects. However, when these bacteria enter the body through cuts, scrapes, or other openings in the skin, they can cause infections ranging from minor to severe.

Recognizing MRSA Symptoms: More Than Just Itching

While itching can be a symptom of MRSA, it’s important to be aware of the full range of signs that may indicate an infection. MRSA infections often resemble other skin infections, making them challenging to identify without medical expertise.

• Red, swollen, and painful areas on the skin
• Bumps or lesions that may be warm to the touch
• Fluid or pus-filled abscesses
• Fever in some cases

Can MRSA infections spread beyond the skin? In more severe cases, MRSA can indeed invade deeper tissues, potentially affecting the blood, lungs, bones, and joints. This underscores the importance of early detection and treatment.

The Contagious Nature of MRSA: Understanding Transmission

MRSA is highly contagious and can spread through various means. Understanding these transmission routes is crucial for prevention and control.

1. Direct contact with contaminated surfaces
2. Person-to-person contact, especially in crowded environments
3. Sharing personal items like towels, razors, or clothing
4. Self-spread from one body part to another via unclean hands

Who is most at risk for MRSA infections? While MRSA was once primarily associated with healthcare settings and immunocompromised individuals, community-acquired MRSA has become increasingly common. This means that even healthy individuals outside of hospital environments can contract the infection.

The Concept of MRSA Carriers

Some individuals can be asymptomatic carriers of MRSA, harboring the bacteria without showing signs of infection. These carriers can unknowingly spread the bacteria to others, highlighting the importance of good hygiene practices for everyone.

Diagnosing MRSA: The Importance of Professional Assessment

Given the similarity between MRSA and other skin infections, professional medical diagnosis is crucial. How do doctors diagnose MRSA?

• Physical examination of the affected area
• Collection of pus or blood samples for laboratory testing
• Bacterial culture to identify the specific strain and its antibiotic resistance

Why is accurate diagnosis so important? Proper identification of MRSA allows for targeted treatment, reducing the risk of complications and preventing the spread of the infection to others.

MRSA Treatment Strategies: Tailored Approaches for Effective Management

Treatment for MRSA infections varies depending on the severity and location of the infection. What are the primary treatment methods for MRSA?

• Drainage of abscesses to remove accumulated pus
• Topical antibiotics for mild, localized infections
• Oral antibiotics effective against MRSA strains
• Intravenous antibiotics for severe or systemic infections

Which antibiotics are effective against MRSA? While MRSA is resistant to many common antibiotics, certain medications such as vancomycin, daptomycin, or linezolid may be prescribed. The choice of antibiotic depends on the specific strain and the patient’s individual circumstances.

The Importance of Completing Antibiotic Courses

To prevent further antibiotic resistance and ensure effective treatment, it’s crucial to complete the entire prescribed course of antibiotics, even if symptoms improve before the medication is finished.

Preventing MRSA: Proactive Measures for Individual and Community Health

Prevention is key in managing the spread of MRSA. What steps can individuals and communities take to reduce the risk of MRSA infections?

1. Practice proper hand hygiene with soap and water or alcohol-based sanitizers
2. Keep cuts and wounds clean and covered
3. Avoid sharing personal items that come into contact with skin
4. Clean and disinfect shared equipment, especially in athletic settings
5. Maintain good personal hygiene and cleanliness in living spaces

How can educational institutions contribute to MRSA prevention? Schools and universities can implement policies for regular cleaning of shared spaces, promote good hygiene practices, and educate students about the risks and prevention of MRSA.

Parental Guidance: When to Seek Medical Attention for Potential MRSA

Parents play a crucial role in identifying and addressing potential MRSA infections in their children. When should parents consult a healthcare provider?

• If a child develops a red, swollen, painful skin area, especially if accompanied by pus or fever
• When skin infections seem to be spreading among family members or classmates
• If multiple family members develop skin infections simultaneously

Why is early intervention important? Prompt medical attention can lead to faster diagnosis and treatment, reducing the risk of complications and preventing the spread of MRSA to others in the household or community.

The Broader Impact: Antibiotic Resistance and Public Health

The emergence of MRSA is part of a larger issue of antibiotic resistance, which poses significant challenges to public health. How does misuse of antibiotics contribute to this problem?

• Taking antibiotics for viral infections, which they cannot treat
• Not completing prescribed antibiotic courses
• Using antibiotics prescribed for others

What can individuals do to combat antibiotic resistance? By using antibiotics responsibly and only as prescribed, we can help slow the development of resistant bacteria. This includes never sharing prescriptions and always completing the full course of antibiotics unless otherwise directed by a healthcare provider.

The Role of Research and Development

Ongoing research into new antibiotics and alternative treatments is crucial in the fight against MRSA and other resistant bacteria. How are scientists approaching this challenge? Researchers are exploring novel antibiotics, bacteriophage therapy, and strategies to boost the human immune system’s ability to combat resistant infections.

MRSA in Healthcare Settings: A Persistent Challenge

While community-acquired MRSA has become more common, healthcare-associated MRSA remains a significant concern. Why are healthcare settings particularly vulnerable to MRSA outbreaks?

• High concentration of immunocompromised patients
• Frequent use of invasive procedures and devices
• Close proximity of patients in hospital wards
• Potential for antibiotic overuse

What measures are healthcare facilities implementing to combat MRSA? Many hospitals and clinics have adopted comprehensive infection control protocols, including:

1. Strict hand hygiene policies for staff and visitors
2. Isolation precautions for MRSA-positive patients
3. Regular environmental cleaning and disinfection
4. Antibiotic stewardship programs to promote responsible use

The Economic Impact of MRSA

MRSA infections can have significant economic consequences for both individuals and healthcare systems. How does MRSA affect healthcare costs? Extended hospital stays, specialized treatments, and lost productivity due to MRSA infections contribute to increased healthcare expenditures and economic burden.

Living with MRSA: Long-term Management and Quality of Life

For individuals who have experienced MRSA infections, long-term management is crucial to prevent recurrence and maintain quality of life. What strategies can help in managing MRSA long-term?

• Maintaining vigilant hygiene practices
• Regular check-ups with healthcare providers
• Prompt attention to any new skin abnormalities
• Educating family members and close contacts about MRSA prevention

Can MRSA be completely eradicated from the body? While active infections can be treated, some individuals may continue to carry MRSA bacteria. In these cases, the focus shifts to preventing new infections and minimizing the risk of transmission to others.

Psychological Impact of MRSA

Living with MRSA or recovering from a severe infection can have psychological effects. How can individuals cope with the stress and anxiety associated with MRSA? Support groups, counseling, and education about the condition can help individuals and families navigate the challenges of living with or recovering from MRSA.

Future Directions: Innovations in MRSA Prevention and Treatment

As MRSA continues to pose challenges to public health, researchers and medical professionals are exploring innovative approaches to prevention and treatment. What are some promising areas of research in combating MRSA?

• Development of new classes of antibiotics
• Exploration of combination therapies
• Research into bacterial communication disruption
• Investigation of natural antimicrobial compounds
• Advancements in rapid diagnostic techniques

How might these innovations change the landscape of MRSA management? By providing more effective treatments, faster diagnoses, and novel prevention strategies, these advancements could significantly reduce the impact of MRSA on individuals and communities.

The Role of Global Collaboration

Addressing the challenge of MRSA requires a coordinated global effort. How are international organizations contributing to the fight against MRSA? Bodies like the World Health Organization are working to promote antibiotic stewardship, fund research, and facilitate the sharing of best practices across borders.

In conclusion, MRSA represents a significant challenge in modern healthcare, but through a combination of awareness, prevention strategies, responsible antibiotic use, and ongoing research, we can work towards mitigating its impact. By staying informed and proactive, individuals and communities can play a crucial role in controlling the spread of MRSA and maintaining public health.

MRSA (for Parents) – Nemours KidsHealth

en español: Infecciones por SARM

Reviewed by: Elana Pearl Ben-Joseph, MD

What Is MRSA?

MRSA is a type of staph bacteria. MRSA (say: MUR-suh) stands for methicillin-resistant Staphylococcus aureus. It causes infections that can be hard to treat.

Many people have staph bacteria living harmlessly on their skin or in their noses. Staph bacteria that enter the body through a cut, scrape, or rash can cause minor skin infections. Most of these heal on their own if the wound is kept clean and bandaged, but sometimes antibiotics are needed.

MRSA differs from other staph bacteria because it doesn’t respond well to most of the antibiotics used to treat staph infections. Bacteria that are hard to kill are called “resistant.” They become resistant by changing in some way that prevents the antibiotic from doing its job. Methicillin is an antibiotic normally used to treat staph, so these bacteria are called “methicillin-resistant. “

What Are the Signs & Symptoms of MRSA?

MRSA infections look like other skin infections. They often develop around open sores, but also happen on intact skin. There can be red, swollen, painful areas or bumps on the affected skin. They sometimes ooze fluid or pus (an infected area with pus is an abscess). Some kids also have a fever.

In more serious cases, the infection can spread to the blood, lungs, bones, joints, or other parts of the body.

Is MRSA Contagious?

MRSA is contagious. Like all other staph bacteria, it can spread:

• when someone touches a contaminated surface
• from person to person, especially in places where large groups of people are close together (like schools, camps, or college dorms). Often this happens when people with skin infections share personal things like razors, bed linens, towels, or clothing.
• from one area of their body to another, by dirty hands or fingernails

In the past, MRSA mostly affected people in nursing homes or hospitals. It was more likely to be seen in people with weak immune systems. It was also more common in people who had a surgical wound. But now some otherwise healthy people outside of those settings are getting the infection.

Sometimes, people can be “carriers” of MRSA. This means that the bacteria stay on or in their bodies for days, weeks, or even years without causing symptoms. But they can spread it to others. That’s why washing hands well and often is so important.

How Is MRSA Diagnosed?

A doctor will examine the affected skin, and sometimes will take a sample of pus or blood. This goes to a lab for testing to find out which bacteria are causing the infection.

How Is MRSA Treated?

Treatment depends on what the infection looks like:

• If there is an abscess, the doctor might make a small cut in the skin over it to let the pus drain out.
• The doctor may prescribe an antibiotic, either to put on the skin or to be taken by mouth (some antibiotics still work for MRSA).
• Someone with a more severe infection might get intravenous (IV) antibiotics in a hospital.

Can MRSA Be Prevented?

These simple steps can help prevent MRSA infections:

• Adults and kids should wash their hands well and often with soap and warm water for at least 20 seconds. Alcohol-based hand sanitizers or wipes are OK if soap and water aren’t handy.
• Do not touch or pick at infected areas. Cuts or broken skin should be cleaned and covered with a bandage.
• Don’t share razors, towels, uniforms, or other items that come into contact with bare skin.
• If sports equipment must be shared, cover it with a barrier (clothing or a towel) to prevent skin from touching it. The equipment also should be cleaned before each use with a disinfectant that works against MRSA.

How Can Parents Help?

Call the doctor if:

• Your child has a skin area that is red, painful, swollen, and/or filled with pus, especially if he or she has fever or feels sick.
• Skin infections seem to be passing from one family member to another (or among students at school), or if two or more family members have skin infections at the same time.

What Else Should I Know?

Bacteria become resistant to antibiotics when they are not used properly. This includes:

• taking antibiotics for things they can’t cure, like illnesses caused by viruses
• not taking all the medicine prescribed
• taking medicine that was prescribed for someone else

Taking antibiotics exactly as prescribed can help stop bacteria from becoming resistant to them. Take these precautions:

• Never give your child someone else’s prescription.
• Don’t save antibiotics for “next time.”
• Always give antibiotics as directed until the prescription is done (unless a doctor says it’s OK to stop early).

Reviewed by: Elana Pearl Ben-Joseph, MD

Date reviewed: October 2019

Share:

/content/kidshealth/misc/medicalcodes/parents/articles/mrsa

Is Itch Intensity in Atopic Dermatitis Associated with Skin Colonization by Staphylococcus aureus?

Indian J Dermatol. 2020 Jan-Feb; 65(1): 17–21.

doi: 10.4103/ijd.IJD_136_19

,^{,1,1,2, and}

Author information Article notes Copyright and License information Disclaimer

Background:

Atopic dermatitis (AD) is a highly pruritic skin condition of unclear pathogenesis. Patients with AD are predisposed to colonization by Staphylococcus aureus due to deficiencies in the mechanical and immunological functions of the skin barrier. Recent studies indirectly show that S. aureus may aggravate disease flares in AD.

Aims:

The aim was to assess the relationship between S. aureus skin colonization and itch intensity in patients with AD.

Materials and Methods:

The SCORAD index components reflecting itch intensity (excoriations, subjective evaluation of pruritus, and sleep loss) were assessed in 33 adult patients with AD. Swabs were taken from lesional and nonlesional skin. The prevalence and abundance of S. aureus were assessed. Statistical analysis was performed to correlate the microbiological results with the clinical parameters. The control group consisted of 36 healthy volunteers.

Results:

Lesional and nonlesional skin showed a high frequency of S. aureus colonization when compared with controls (81.8% and 57.6% vs 5.6%, respectively, P < 0.0001). The mean concentration (points) of S. aureus was 2.01 ± 1.25, 1.06 ± 1.14, and 0.11 ± 0.46, respectively (P < 0.0001). S. aureus abundance on lesional/nonlesional skin positively correlated with excoriations and sleep loss (rho = 0.69, P < 0.00001; rho = 0.44, P < 0.01; rho = 0.41, P < 0.02; and rho = 0.34, P < 0.05, respectively). The mean values of excoriations were higher in patients colonized by S. aureus than in patients without S. aureus carriage.

Conclusion:

S. aureus skin colonization may be one of the factors aggravating itch in AD. It may be hypothesized that restoring the natural composition of the skin microbiome may reduce pruritus intensity.

KEY WORDS: Atopic dermatitis, itch, Staphylococcus aureus

Atopic dermatitis (AD) is a chronic skin condition presenting with eczematous lesions and accompanied by intense pruritus.[1] Itch is a major diagnostic criterion of AD[2] and it poses a primary therapeutic challenge in this disease.[3] Pruritus can be mediated by histaminergic and non-histaminergic pathways, but its pathogenesis in AD remains unexplained.[4]

Although histamine was initially thought to be the most important itch mediator, its role in AD is limited. Other itch mediators include 5-hydroxytryptamine, bradykinin, substance P, and various interleukins, such as IL-4, IL-6, and IL-31.[5] IL-31, a Th3-dependent molecule, is especially important in AD. Its upregulation is observed in the atopic skin, and it is considered as one of the most important targets for biological treatment in the future. [6,7] Genetically conditioned epithelial barrier dysfunction and imbalance in the profile of the immunological response in patients with AD facilitate colonization by different skin pathogens, including Staphylococcus aureus.[8] IL-31 can be upregulated by S. aureus antigens which implies that this pathogen can aggravate not only disease flares but also the itch in AD.[9]

The aim of this study was to assess the relationship between S. aureus skin colonization and itch intensity in patients with AD.

Thirty-three Polish adult patients with active AD were enrolled in the study. The patients’ characteristics are presented in . The diagnosis was confirmed based on Hanifin and Rajka criteria.[4] The exclusion criteria were the following: other dermatoses, clinical signs of skin infection, immunosuppression (either iatrogenic or intrinsic), heart, renal and hepatic failure, diabetes, diagnosis of cancer, and lack of consent. Daily administration of emollients without the addition of potentially bactericidal and/or bacteriostatic agents and of oral antihistamines was accepted. Topical steroids and calcineurin inhibitors were discontinued 5 days before the evaluation. The control group consisted of 36 healthy volunteers sex- and age-matched. The study was approved by the Ethics Board of the Medical University of Warsaw. All participants gave their informed consent before inclusion in the study.

Table 1

Clinical characteristics of the study group

Variable	Value
Constitutional parameters
Women/men	14/19 (42.4%/57.6%)
Age (years)	Range 18-68; mean 31.4±11.9
SCORAD index components reflecting itch intensity (points)
Excorations	Range 0-3, mean 1. 27±0.91
Pruritus	Range 1-10, mean 6.27±2.86
Sleeplessness	Range 0-10, mean 3.97±3.64

Open in a separate window

The SCORAD index components reflecting itch intensity, that is, excoriations (0–3 points), subjective evaluation of pruritus (1–10 points), and sleep loss (0–10 points) were assessed.[10] Every patient had a swab taken from a skin lesion and nonlesional skin (volar forearm, if noninvolved). The same investigator (LB) was responsible for the clinical assessment of patients and swab collection.

The swabs used for collecting the biological material were cotton-wool tipped. The transport medium was Stuart (MedLab). Before taking a sample, each swab was wet in 0.85% NaCl solution (Biomerieux). To take the skin swabs, an area of 4 cm² was rubbed for 5 seconds. The swabs were plated on Petri dishes with mannitol-salt agar. The incubation for up to 40 hours was carried out in aerobic conditions at 37°C. Based on distinct morphology, obtained colonies were isolated for identification with Vitek MS-DS mass spectrometer. Colonies of the identified S. aureus strains were counted in the cultures to semi-quantify the concentration of S. aureus in the investigated niches. The number of bacterial colony forming units (CFU) was determined based on the correlation with the number of colonies of S. aureus present in the culture and assigned a score on a 0 to 3 point scale (0 pts – no growth, 1 point – up to 10 colonies, 10² CFU; 2 points – up to 100 colonies, 10³ CFU; 3 points – over 100 colonies, 10⁴ CFU and above).

The results were statistically analyzed to correlate the microbiological analysis with the obtained clinical parameters. The frequency table method was used to describe qualitative variables, and a typical measure of position (mean, median) and variability (standard deviation) were used to describe quantitative variables. For selected pairs of variables, associations/correlations were examined. The Chi-square test [with the Yates correction for small groups (n < 5)] was used to test the relationships between categorical variables. In cases when the number of observations was lower than 50, Fisher’s test was applied. To compare two groups, Wilcoxon rank sum test with continuity correction was used, except attributes with a normal distribution, where the Welch two-sample t-test was applied. Spearman’s rank correlation method was used to measure the degree of the relationship between quantitative and other variables, except the case of normal distribution, where Pearson’s correlation was applied. To identify normal distribution, Shapiro–Wilk normality test was used. The standard level of P value threshold was assumed as P < 0.05.

S. aureus was isolated in 81.8% (27/33) and 57.6% (19/33) of samples from lesional skin and nonlesional skin, respectively (P < 0. 04). The control group was colonized in 5.6% (2/36) (P < 0.0001).

The mean S. aureus concentration on lesional, nonlesional, and control group skin was 2.01 ± 1.25, 1.06 ± 1.14, and 0.11 ± 0.46, respectively. All differences were statistically significant (P < 0.001).

S. aureus concentration on lesional and nonlesional skin positively correlated with excoriations (rho = 0.69, P < 0.00001 and rho = 0.44, P < 0.02, respectively) [Figure and ] and sleep loss (rho = 0.41, P < 0.02 and rho = 0.34, P < 0.05, respectively) [Figure and ]. Compared with the patients without S. aureus carriage, the carriers of S. aureus on lesional skin had significantly higher mean values of excoriations (1.54 ± 0.81 vs 0.29 ± 0.49, P < 0.001) and sleep loss (4.65 ± 3.71 vs 1.43 ± 1.99, P < 0.05). Patient-reported itch intensity was also higher in the carriers, but the difference was not statistically significant (data not shown).

Open in a separate window

Spearman’s correlations between excoriations/sleep loss and the concentration of Staphylococcus aureus on lesional (a and b) and nonlesional (c and d) skin

Patients colonized by S. aureus on nonlesional skin had higher mean values of excoriations (1.58 ± 0.90 vs 0.88 ± 0.77, P < 0.029) than noncolonized individuals. The mean values of declared itch intensity and sleep loss were higher in the colonized patients, but the difference was not statistically significant (data not shown).

The study confirmed the observations of other authors that S. aureus colonization of lesional and nonlesional skin is a common feature of AD.[11] S. aureus concentration was high in the investigated microniches, which suggested that most patients with AD showed an inability to control S. aureus colonization. This may result from the dysfunctional innate and acquired immune responses as well as epithelial barrier damage. [12] Given the highest abundance of S. aureus on lesional skin in comparison to nonlesional and healthy skin, insufficient physical skin barrier seems to play the most important role in S. aureus colonization.

Kong et al. have shown that S. aureus dominates the microbiome of skin lesions and its abundance in this location correlates with disease severity.[8] The increase in S. aureus concentration precedes AD flares, which suggests that it may be a triggering factor for relapses. It has been shown that many molecules produced by S. aureus act as proteases, superantigens, and facilitators of viral infections and keratinocyte apoptosis.[13] Clinically, these virulence factors have the potential to increase skin inflammation, which is associated with the intensification of pruritus.

The assessment of pruritus intensity in AD is difficult and the evaluation of excoriations seems to be the most objective tool. The study results showed a positive, statistically significant correlation between S. aureus abundance on lesional and nonlesional skin and excoriations. This suggests that an increased exposition to the virulence factors of S. aureus is strictly associated with the sensation of pruritus and scratching. In addition, in the binary analysis, the mean values of excoriations were higher in patients colonized by S. aureus than in patients without S. aureus carriage.

The subjective evaluation of sleep loss and pruritus was less strictly associated with S. aureus colonization in this study. A statistically significant correlation between sleep loss and S. aureus abundance on lesional and nonlesional skin was observed. However, the mean values of sleep loss were significantly higher only in patients with S. aureus colonization on lesional skin when compared with the noncarriers. There was no statistically significant association between itch severity reported by patients and S. aureus colonization on both lesional and nonlesional skin. Nevertheless, it must be pointed out that patients with AD experience itch and sleep loss in a highly individual manner. Furthermore, SCORAD analysis of the subjective symptoms refers only to the past 3 days, while excoriations are more objective and long-lasting signs of pruritus. In future studies, the effort should be made to precisely evaluate excoriations and perhaps identify other objective itch determinants. It could also be advisable to use scales designed to assess itch intensity more accurately. One of the tools recently validated in different languages is the ItchyQol which can be used in clinical trials.[14]

Although itch pathogenesis is complex, some of its mediators have been identified and their levels can be influenced by S. aureus. Hodille et al.[15] have shown that delta-hemolysin and phenol-soluble modulins produced by S. aureus, induced degranulation of human mast cells in a dose-dependent manner. Itch in AD is not directly associated with the histamine pathway, but these results suggest that the overabundance of S. aureus may contribute to the intensity of pruritus through this mechanism.

Recent studies have described the role of IL-31 in the itch pathogenesis.[16] IL-31 has been proved to cause symptoms of dermatitis and to aggravate pruritus in animal models.[17] Overexpression of IL-31 has been reported in the skin of subjects with AD and prurigo nodularis.[9] This molecule is mainly produced by Th3 cells previously stimulated by IL-4.[18] IL-31 is bound by receptors present on the surface of keratinocytes, eosinophils, and neurons of smaller diameter.[19] The exact mechanism through which IL-31 causes the sensation of pruritus is not understood yet.

The antigens of S. aureus have been reported to induce IL-31 in vivo and in vitro in individuals with AD.[9] Whether this is secondary to the hyperstimulation of the Th3-type response or other mechanisms is not certain. Importantly, the strong sensation of pruritus mediated by IL-31 provokes scratching and skin barrier damage.

It has been proposed that the adherence of S. aureus to the skin of patients with AD is facilitated due to the impairment of the epithelial barrier and altered exposition of natural moisturizing factor and filaggrin. Defective corneocytes are easily bound by clumping factor B of S. aureus.[20] It is highly possible that the ability of S. aureus to adhere to the damaged skin surface results in a vicious cycle: skin colonization, exposition to the virulence factors with secondary upregulation of itch mediators, scratching, and further destruction of the epithelial barrier.

Scratching may also lead to dissemination of S. aureus and other pathogens between different niches. This is especially important in the context of frequently observed bacterial and viral skin infections in AD.

Based on the results of the present and above-mentioned studies, the authors propose that microbial dysbiosis should be treated and prevented in AD to reduce pruritus. Patients with AD are advised to use special clothing containing silver ions and bathe regularly with fragrance-free detergents.[21] Recently, bleach baths have been reported to alleviate AD symptoms, reduce S. aureus colonization in children, and be a potential treatment in patients who have undergone more than one therapy with systemic antibiotics during AD flares.[22,23] Another alternative is to add small amounts of potassium permanganate to the bathing water.[24] In the future, preparations including probiotics, synthetic AMPs, and other novel antimicrobial agents may prove successful in controlling S. aureus colonization in AD without causing significant bacterial resistance and side effects.[25,26,27,28,29]

Although the study group was small, it seems evident that the S. aureus colonization is associated with itch severity in AD. These results should be verified in the trials with larger study groups. Furthermore, at the time of data collection, there were no validated itch assessment scales available in Polish; the determination of itch severity was only based on the SCORAD index.

In conclusion, S. aureus colonization of the skin lesions and nonlesional skin is associated with higher values of itch determinants in AD. S. aureus seems to cause hyperstimulation of the immune system and overexpression of itch mediators. Prevention and therapy of microbiome dysbiosis could help alleviate itch related to AD.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

1. Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. [PMC free article] [PubMed] [Google Scholar]

2. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovenereol (Stockholm) Suppl. 1980;92:44–7. [Google Scholar]

3. Pavlis J, Yosipovitch G. Management of itch in atopic dermatitis. Am J Clin Dermatol. 2018;19:319–32. [PubMed] [Google Scholar]

4. Lavery MJ, Kinney MO, Mochizuki H, Craig J, Yosipovitch G. Pruritus: An overview. What drives people to scratch an itch? Ulster Med J. 2016;85:164–73. [PMC free article] [PubMed] [Google Scholar]

5. Song J, Xian D, Yang L, Xiong X, Lai R, Zhong J. Pruritus: Progress toward pathogenesis and treatment. Biomed Res Int. 2018;2018:9625936. [PMC free article] [PubMed] [Google Scholar]

6. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C, et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: A model of atopic dermatitis. Exp Dermatol. 2009;18:35–43. [PubMed] [Google Scholar]

7. Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. Allergy. 2018;73:29–36. [PubMed] [Google Scholar]

8. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22:850–9. [PMC free article] [PubMed] [Google Scholar]

9. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411–7. [PubMed] [Google Scholar]

10. Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology. 1993;186:23–31. [PubMed] [Google Scholar]

11. Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly NK. Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian J Med Res. 1992;95:234–8. [PubMed] [Google Scholar]

12. Boothe D, Tarbox JA, Tarbox MB. Atopic dermatitis: Pathophysiology. Adv Exp Med Biol. 2017;1027:21–37. [PubMed] [Google Scholar]

13. Paller AS, Kong GG, Seed P, Naik S, Scharschmidt TC, Gallo RL, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143:26–35. [PMC free article] [PubMed] [Google Scholar]

14. Zeidler C, Steinke S, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Cross-European validation of the ItchyQoL in pruritic dermatoses. J Eur Acad Dermatol Venereol. 2019;33:391–7. [PubMed] [Google Scholar]

15. Hodille E, Cuerq C, Badiou C, Bienvenu F, Steghens JP, Cartier R, et al. Delta hemolysin and phenol-soluble modulins, but not alpha hemolysin or panton-valentine leukocidin, induce mast cell activation. Front Cell Infect Microbiol. 2016;6:180. [PMC free article] [PubMed] [Google Scholar]

16. Nakashima C, Otsuka A, Kabashima K. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis. Exp Dermatol. 2018;27:327–31. [PubMed] [Google Scholar]

17. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5:752–60. [PubMed] [Google Scholar]

18. Bagci IS, Ruzicka T. IL-31: A new key player in dermatology and beyond. J Allergy Clin Immunol. 2018;141:858–66. [PubMed] [Google Scholar]

19. Saleem MD, Oussedik E, D’Amber V, Feldman SR. Interleukin-31 pathway and its role in atopic dermatitis: A systematic review. J Dermatolog Treat. 2017;28:591–9. [PubMed] [Google Scholar]

20. Fleury OM, McAleer MA, Feuillie C, Formosa-Dague C, Sansevere E, Bennett DE, et al. Clumping factor B promotes adherence of staphylococcus aureus to corneocytes in atopic dermatitis. Infect Immun. 2017;85:e00994–16. [PMC free article] [PubMed] [Google Scholar]

21. Farmer WS, Marathe KS. Atopic dermatitis: Managing the itch. Adv Exp Med Biol. 2017;1027:161–77. [PubMed] [Google Scholar]

22. Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: Clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35:161–83. [PMC free article] [PubMed] [Google Scholar]

23. McPherson T. Current understanding in pathogenesis of atopic dermatitis. Indian J Dermatol. 2016;61:649–55. [PMC free article] [PubMed] [Google Scholar]

24. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123:808–14. [PubMed] [Google Scholar]

25. Ng SMS, Teo SW, Yong YE, Ng FM, Lau QY, Jureen R. Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections. Chem Biol Drug Des. 2017;90:1155–60. [PubMed] [Google Scholar]

26. Dawgul M, Baranska-Rybak W, Piechowicz L, Neubauer D, Nowicki R, Kamysz W. The antistaphylococcal activity of citropin 1. 1 and temporina against planktonic cells and biofilms formed by isolates from patients with atopic dermatitis: An assessment of their potential to induce microbial resistance compared to conventional antimicrobials. Pharmaceuticals (Basel) 2016;9:E30. [PMC free article] [PubMed] [Google Scholar]

27. Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9:4680. [PMC free article] [PubMed] [Google Scholar]

28. Fischetti VA. Lysin therapy for staphylococcus aureus and other bacterial pathogens. Curr Top Microbiol Immunol. 2017;409:529–40. [PubMed] [Google Scholar]

29. Mottin VHM, Suyenaga ES. An approach on the potential use of probiotics in the treatment of skin conditions: Acne and atopic dermatitis. Int J Dermatol. 2018;57:1425–32. [PubMed] [Google Scholar]

Treatment of staph infection: effective methods and remedies

Content

• 1 How to get rid of staph infection: symptoms, treatment and prevention
  • 1. 1 Symptoms of staph infection
  • 1.2 Causes of staph infection 900 08
  • 1.3 Main types of staphylococcal infection
  • 1.4 Diagnosis of staph infection
  • 1.5 Treatment of staph infection with antibiotics
  • 1.6 Ointments and creams are effective in the treatment of staph infection
  • 1.7 The use of physiotherapy in the treatment of staph infection
  • 1.8 Herbal medicine in the fight against staph infection
    • 1.8.1 What is a staph infection?
    • 1.8.2 How can phytotherapy help?
    • 1.8.3 Which plants can be used?
    • 1.8.4 What effect can be expected?
  • 1.9 Homeopathy in the fight against staph infection
  • 1.10 Prevention of staph infection
    • 1.10.1 General recommendations
    • 1.10.2 Specific advice
  • 1.11 When to see a doctor if a staph infection is suspected
  • 1.12 Q&A:
    • • 1.1 2.0.1 What causes a staph infection?
      • 1. 12.0.2 What are the symptoms of a staph infection?
      • 1.12.0.3 Can a staph infection be treated without antibiotics?
      • 1.12.0.4 Which antibiotics can be used to treat a staph infection?
      • 1.12.0.5 Which specialists treat staph infections?
      • 1.12.0.6 How can staph infection be prevented?

Learn how to properly treat a staph infection, step by step instructions, effective methods and remedies to quickly get rid of the disease. Tips and advice from professionals in the field.

Staphylococcal infections can be caused by many types of bacteria, but Staphylococcus aureus is the most common. It can manifest itself as a violation of the skin, and damage to internal organs, which can become life-threatening. Treatment of a staphylococcal infection should be started immediately to prevent complications and progression of the disease.

Various methods and agents are used to treat staphylococcal infections. One of the main methods is antibiotic therapy, which is aimed at removing the pathogen from the body. In addition, the use of anti-inflammatory and analgesic drugs, as well as local treatment of lesions of the skin and mucous membranes, is indicated.

In this article, we will consider effective methods and tools used in the treatment of staphylococcal infections. We will also talk about the principles of choosing medicines and their use, as well as the prevention of recurrent diseases.

Symptoms of staph infection

Staph infection is a disease caused by the bacterium Staphylococcus aureus. It can lead to various diseases such as boils, skin folds, pyoderma, pneumonia, meningitis and others.

The main signs of a staphylococcal infection are:

• Appearance of painful red blisters, swelling and rashes on the skin
• Discharge of purulent fluid
• Fever
• Pain, discomfort and burning sensation in the affected areas
• Headache and nausea when the lungs and meninges are infected

other people.

Causes of staphylococcal infections

Staphylococcal infections are caused by the bacteria Staphylococcus aureus, which are part of the normal flora of the human skin and respiratory tract. They can enter the body through small wounds, cuts, inflamed skin, mucous membranes, or through through catheters.

Staphylococcus can also be transmitted through coughing, sneezing, touching contaminated objects and surfaces, contaminated food and water. Infection can occur in people who are immunosuppressed, in children, in people who are often at risk (such as in hospitals), and when taking antibiotics for a long time.

• Risk factors:
  • Lack of personal hygiene;
  • Weakened immunity;
  • Sleep deprivation, prolonged exposure to stressful situations;
  • Malignant tumors;
  • Diabetes mellitus;
  • Sports and professions associated with skin injuries.

Staphylococcus aureus often becomes resistant to many types of antibiotics, making it difficult to treat the infection. Therefore, it is important to maintain personal hygiene, follow a healthy lifestyle and immediately consult a doctor if signs of illness appear.

The main types of staphylococcal infections

Staphylococci are coccal bacteria that are found in large numbers on the skin and in the nasopharynx in healthy people. But they are also one of the most common human bacterial infections. There are several main types of staph infection, which include:

• Skin infections: is the most common type of staph infection and presents as boils (Gibson’s disease is a large, purulent, inflammatory nodule on the skin), septicemia or other infections, wound infection, and osteomyelitis (chronic bone inflammation).
• Pneumonia: If staphylococcus aureus enters the lungs through the bloodstream, it can lead to pneumonia.
• Food poisoning: staphylococci can produce toxins that cause food poisoning after eating contaminated food.
• Toxic shock: is a rare but potentially fatal type of staph infection that presents with high fever, low blood pressure, organ failure, and a rash all over the body.

Comparison of the main types of staph infection

901 57 Furuncles, septicemia, wound infection, osteomyelitis

Diagnosis of staph infection

Diagnosis of staph infection requires a microbiological test that will show the presence of staphylococci in the blood or infected material.

Also, blood tests can be done to diagnose a staph infection, including a complete blood count and biochemical analysis, which can indicate the presence of inflammation in the body.

More specific testing methods, such as PCR diagnostics or immunofluorescence testing, can be used to accurately determine the type of staphylococcus aureus.

Treatment of staph infection with antibiotics

Staph infection is a serious disease caused by bacteria of the staph type. For its treatment, complex therapy is usually required, including both a general recovery of the body and the use of antibiotics.

The choice of specific antibiotic depends on the type of infection, the source of infection, and comorbidities. The following groups of antibiotics are often used in the treatment of staphylococcal infections:

• Penicillins. They are most effective in treating staphylococcal infections, but may cause allergic reactions.
• Cephalosporins. These antibiotics are broad spectrum and are often used in the treatment of complicated cases of staph infections.
• Macrolides. They are effective in treating infections caused by certain types of staphylococci, but are not recommended for long-term use due to possible side effects.

In addition, in some cases it may be necessary to use powerful antibiotic therapy with several antibiotics, for example, in the case of acute pancreatitis.

It is important to remember that improper use of antibiotics can lead to bacterial resistance, so treatment of staphylococcal infections with antibiotics should be carried out under the supervision of a physician and in strict accordance with the recommended regimens.

Ointments and creams are effective in the treatment of staphylococcal infections

One of the most effective and popular ways to treat a staph infection is to use ointments and creams. They are local preparations that are applied to the affected skin and are able to quickly cope with a bacterial infection.

Some of the more popular ointments and creams for staph infections include Mupirocin, Erythromycin, Clotrimazole, Fucidic Acid, and others. However, before using such drugs, you should consult your doctor and carefully read the instructions.

It is important to remember that the use of ointments and creams is not an independent treatment for staph infection and must be combined with other methods such as antibiotics, hygiene, etc.

The use of physiotherapy in the treatment of staph infection

Physiotherapy is a commonly used method in the treatment of staph infection. It is prescribed by a doctor after a comprehensive examination of the patient and determining the degree of development of the infection.

One of the most effective methods of physiotherapy is ultraviolet irradiation of the affected areas of the skin. UV irradiation significantly reduces the growth of bacteria and accelerates the healing process of wounds. In addition, there are no side effects observed with this method of treatment.

Another effective method of physiotherapy is magnetotherapy. It helps to speed up the process of tissue regeneration and enhances the patient’s immunity. In addition, magnetotherapy helps relieve pain and reduce swelling of the affected areas.

• Some of the benefits of using physiotherapy:
  1. Does not require the use of drugs, which reduces the risk of side effects;
  2. Accelerates the process of wound healing and tissue regeneration;
  3. Boosts immunity and helps prevent future relapses;
  4. Is a safe treatment with no high toxicity.

However, it should be noted that physiotherapy can only be used in combination with other treatments for staphylococcal infections. The effectiveness of physiotherapy can be significantly increased if the patient follows the correct daily routine, follows a diet and takes a course of antibiotics.

Phytotherapy in the fight against staphylococcal infection

What is staphylococcal infection?

Staphylococci are bacteria that can cause various infections in humans, including skin and respiratory infections. These bacteria often live on our skin, but under certain conditions they can become harmful.

How can herbal medicine help?

Phytotherapy is a treatment based on herbal preparations. Some plants can help fight staph due to their antimicrobial and anti-inflammatory properties.

Which plants can be used?

• Garlic – contains alicin, which has antimicrobial properties. It can be added to food or consumed in capsule form.
• Tea Tree – Tea tree essential oil also has antimicrobial properties. It can be used to treat skin infections.
• Golden root – strengthens the immune system and helps fight bacteria. It can be taken as an infusion or in capsules.

What effect can be expected?

Phytotherapy cannot replace antibiotic treatment, but in combination with it, it can enhance its effect and help to cope with the infection faster. In addition, herbal preparations can strengthen the immune system and prevent recurring infections.

Homeopathy in the fight against staphylococcal infection

Staphylococcal infection is a serious disease that can lead to various complications and even death. Treatment of this disease can be long and not always effective.

One of the treatments for staphylococcal infection is the use of homeopathy. Homeopathy is a method of healing based on the belief that like cures like. Homeopathy uses natural substances, with dosage playing a key role in therapy.

Homeopathic medicines used in the treatment of staph infection help to increase the body’s immunity, reduce inflammation and speed up recovery of health.

One of the most effective homeopathic remedies in the treatment of staph infection is Kali bichromicum. It helps to reduce the abundance of secretions, reduce coughing, and also improve the general condition of the body. In addition, this drug is antiseptic and perfectly fights against staphylococci.

But it must be understood that homeopathy is not the only treatment for staphylococcal infection and the use of homeopathic medicines should only take place after consultation with an experienced homeopath.

Prevention of staph infection

General advice

Practice good hand hygiene:

• Wash hands with soap;
• Use hand sanitizer;
• Do not touch face with unwashed hands;
• Do not share other people’s personal items.

Reduce contact with affected skin:

• Avoid close contact with infected people;
• Do not touch your affected skin areas;
• Wear clothing that covers affected skin.

Specific advice

See a doctor if symptoms occur:

• Skin rash;
• Purulent discharge;
• Fever;
• Pain in muscles or joints.

Get certain measures if you are at risk:

• Keep shaving device clean;
• Use only your own personal items;
• Keep the overcooking agent clean.

The most important thing is to take care of your health! Staphylococcal infection, like any other infection, is easier to prevent than to treat.

When to see a doctor if you suspect a staph infection

Staphylococcus is a fairly common type of bacteria that infects human skin. The development of staphylococcal infection can occur both after contact with the patient, and under the condition of hygienic problems. The main symptoms of this infection are: skin rash, itching, swelling, redness of the skin or fever.

Not every case of contact with a patient with a staphylococcal infection is considered justified for going to the doctor. The question is how quickly and successfully the infection can cover large areas of the body and cause serious discomfort. Therefore, it is advisable to consult a doctor if there are frequent relapses, localized foci, when the damaged skin has come into contact with the surrounding space and there is no temporary effect from the treatment.

It is also worth noting that the risk of skin infections can be easily reduced by following basic hygiene rules and taking good care of your health.

Q&A:

What causes a staphylococcal infection?

Staphylococcal infection is caused by the bacterium Staphylococcus aureus, which can be found on the skin or introduced into the body through wounds and cuts, causing various diseases.

What are the symptoms of a staphylococcal infection?

Symptoms may vary depending on the type of infection, but common signs are fever, pain, swelling, redness, itching and discomfort of the skin, headache and nausea.

Can a staph infection be treated without antibiotics?

Treatment without antibiotics is possible for mild infections, but for severe and recurrent cases, antibiotics are necessary and effective.

Which antibiotics can be used to treat a staph infection?

Antibiotics may vary depending on the type of infection and the susceptibility of the bacteria to them. For example, antibiotics from the penicillin, cephalosporins, macrolides, and tetracyclines groups can be used to treat skin infections.

Which specialists treat staph infections?

A staphylococcal infection can be treated by an infectious disease doctor, dermatologist, surgeon, or general practitioner. However, depending on the type of infection, it may be necessary to consult other specialists, such as an ophthalmologist or an otolaryngologist.

How can a staph infection be prevented?

Prevention of staphylococcal infection includes personal hygiene, sterilization of medical instruments, timely treatment of wounds and cuts, avoidance of contact with sick people. It is also recommended to strengthen the immune system and exercise.

Itching all over the body: what are the causes and how to get rid of discomfort?

Itchy skin can throw anyone off balance. Even one mention of itching causes discomfort on an emotional level. To get rid of such an unpleasant sensation, you must first understand the reasons for its occurrence.

What is itchy skin?

At first glance, itchy skin may seem like nothing to worry about. Many years ago, itching was perceived as a kind of pain. But then the doctors realized that this opinion was wrong. There is a direct connection between itching and the functioning of the nervous system. The central nervous system gives commands to scratch or rub a certain area on the body. These signals are sent by the brain.

An example would be a butterfly sitting on a hand. The epidermis, with the help of nerve endings, transmits information to the brain about what has become ticklish. The command is instantly given – look at what is there and, if necessary, dust yourself off, make sure that everything is in order.

But our topic is pruritus and its causes. The factors causing this phenomenon are not very pleasant and are always obvious. This sensation provokes the scratching reflex. The brain gives the command to eliminate the source of itching as soon as possible and return to a comfortable state.

Types of pruritus

There are many causes of pruritus. Some medical institutions have entire departments where they deal with this problem. The desire to scratch the skin at the site of a mosquito bite is familiar to everyone. But the itching that affects the whole body causes insomnia. This problem requires a serious approach. Itching, along with pain, is intense. It can be weak and unbearable, causing you to scratch your skin until it bleeds.

Doctors distinguish two types of itching – localized and generalized.

Localized

This variety includes the same mosquito bite. It has a clear localization, which makes it possible to establish the cause of the uncomfortable phenomenon.

Generalized

In the case of generalized itching, everything is much more complicated. Here you will need the help of a qualified specialist. Itchy skin can be caused by an infection. It can be provoked by diseases of internal organs and even psychological problems.

Itching all over the body – what causes it?

Itching affecting the whole body can be caused by various phenomena. Let’s list the most common reasons.

Dryness of the epidermis

Excessive dryness of the epidermis disrupts the integrity of its hydrolipidic mantle. If the skin began to dry and peel off, as a rule, this phenomenon is accompanied by itching. Discomfort can occur after a shower, for example, if you use soap that dries out the epidermis, along with tap water. In such a situation, itching that affects the body is a signal for help. The skin itself can no longer cope, it is necessary to use moisturizers.

Dry skin is provoked by:

• negative temperatures;
• soap;
• hard tap water;
• low air humidity.

Allergy with urticaria

If the cause of itching is an allergy, histamine causes a feeling that the skin is irritated, there is an involuntary desire to scratch it. Similarly, itching of the skin, provoked by an allergy to cold or photodermatitis, manifests itself. Against this background, itching may appear throughout the body, causing great discomfort. How to get rid of this phenomenon caused by allergies, the allergist will tell. You can also consult a dermatologist.

Parasites, fungi, pathogens, viruses

There are a great many of them. It can be scabies mites or lice, a fungus brought from the pool, a staph infection, or viruses such as herpes.

Various diseases, one of them chicken pox, manifest themselves as a rash that causes the epidermis to itch and itch. In this situation, only a specialist can advise ways to get rid of unpleasant symptoms, prescribe medications for the disease. In the future, to strengthen skin immunity, provide it with good hydration, do not allow severe dryness.

Skin diseases

Many dermatological diseases of non-infectious origin cause itching. This symptom is characteristic of psoriasis, eczema. All of them are caused by damage to the skin, a violation of the microbiome, severe dryness.

In such cases, in addition to therapy, the doctor also prescribes daily care, with which you can reduce the manifestation of the disease, keep the situation under control.

Vitamin deficiency with minerals

This happens when the shortage is very severe. Lack of vitamin D, A, iron adversely affects the epidermis, causes peeling with itching. These symptoms disappear when the deficiency of vitamins is replenished.

Pathologies of the internal organs

Generalized itching may be one of the symptoms of diseases of the internal organs, such as diabetes. Itching occurs when there are disorders in the endocrine system, blood diseases, pathologies of the liver with kidneys, oncology, and neurological problems. Such a symptom is unacceptable to ignore, you need to consult a doctor as soon as possible.

Wrong choice of skin care products

Itching of psychogenic origin makes us itch while reading an article about this phenomenon, when someone is itching next to us. There are no reasons for this. This is what happens on nerves.

Some people scratch their hands when they are nervous or stressed, as if their hands were itchy.